Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

18,003 recalls, newest first

Class II · Moderate risk

Dorama-Neo

Lack of Assurance of Sterility: Firm failed to establish an adequate system for monitoring environmental conditions in aseptic processing areas.

Terminated Sterility / contamination Sato Pharmaceutical Inc. NDC 49873-020-01 D-0856-2017
Class II · Moderate risk

Sato Clear

Lack of Assurance of Sterility: Firm failed to establish an adequate system for monitoring environmental conditions in aseptic processing areas.

Terminated Sterility / contamination Sato Pharmaceutical Inc. NDC 49873-044-01 D-0855-2017
Class II · Moderate risk

Optic Splash

Lack of Assurance of Sterility: Firm failed to establish an adequate system for monitoring environmental conditions in aseptic processing areas.

Terminated Sterility / contamination Sato Pharmaceutical Inc. NDC 49873-501-01 D-0854-2017
Class I · High risk

XtraHRD Natural Male Enhancement Capsules

Marketed without an Approved NDA/ANDA: Product contains N-desmethyl tadalafil an analogue to tadalafil which is an active pharmaceutical ingredient in a FDA approved drug used to treat erectile dysfunction (ED).

Terminated Chemical / undeclared Organic Herbal Supply D-0646-2017

Recalls by year